Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2021 2
2022 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.
Mora B, Guglielmelli P, Kuykendall A, Rumi E, Maffioli M, Palandri F, De Stefano V, Caramella M, Salmoiraghi S, Kiladjian JJ, Gotlib J, Iurlo A, Cervantes F, Ruggeri M, Silver RT, Albano F, Benevolo G, Ross DM, Della Porta MG, Devos T, Rotunno G, Komrokji RS, Casetti IC, Merli M, Brociner M, Caramazza D, Auteri G, Barbui T, Cattaneo D, Bertù L, Arcaini L, Vannucchi AM, Passamonti F. Mora B, et al. Among authors: brociner m. Leukemia. 2022 Oct;36(10):2453-2460. doi: 10.1038/s41375-022-01673-3. Epub 2022 Aug 30. Leukemia. 2022. PMID: 36042316
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.
Maffioli M, Mora B, Ball S, Iurlo A, Elli EM, Finazzi MC, Polverelli N, Rumi E, Caramella M, Carraro MC, D'Adda M, Molteni A, Sissa C, Lunghi F, Vismara A, Ubezio M, Guidetti A, Caberlon S, Anghilieri M, Komrokji R, Cattaneo D, Della Porta MG, Giorgino T, Bertù L, Brociner M, Kuykendall A, Passamonti F. Maffioli M, et al. Among authors: brociner m. Blood Adv. 2022 Mar 22;6(6):1855-1864. doi: 10.1182/bloodadvances.2021006889. Blood Adv. 2022. PMID: 35130339 Free PMC article.
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score.
Barbui T, Ghirardi A, Carobbio A, Masciulli A, Carioli G, Rambaldi A, Finazzi MC, Bellini M, Rumi E, Vanni D, Borsani O, Passamonti F, Mora B, Brociner M, Guglielmelli P, Paoli C, Alvarez-Larran A, Triguero A, Garrote M, Pettersson H, Andréasson B, Barosi G, Vannucchi AM. Barbui T, et al. Among authors: brociner m. Blood Cancer J. 2022 Nov 16;12(11):156. doi: 10.1038/s41408-022-00743-0. Blood Cancer J. 2022. PMID: 36385103 Free PMC article. No abstract available.
Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcome.
Rossi M, Nizzoli ME, Gallì A, Roncoroni E, Zibellini S, Merati G, Rizzo E, Rocca B, Pietra D, Picone C, Brociner M, Tobar Cabrera CP, Gelli E, Santacroce E, Arcaini L, Zappasodi P. Rossi M, et al. Among authors: brociner m. Am J Hematol. 2022 Apr;97(4):E135-E138. doi: 10.1002/ajh.26469. Epub 2022 Jan 24. Am J Hematol. 2022. PMID: 35041232 Free article. No abstract available.
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients.
Salvini M, Damonte C, Mortara L, Maggi F, Bruno A, Pellegrini G, Mora B, Brociner M, Ingrassia A, Mattarucchi R, Bianchi B, Sirocchi D, Agnoli S, Rumi E, Merli M, Fossati A, Bassi S, Bombelli R, Gallazzi M, Borsani O, Baj A, Franchi M, Grossi PA, Passamonti F. Salvini M, et al. Among authors: brociner m. Am J Hematol. 2022 Aug;97(8):E321-E324. doi: 10.1002/ajh.26629. Epub 2022 Jun 24. Am J Hematol. 2022. PMID: 35702859 Free PMC article. No abstract available.
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation.
Salvini M, Maggi F, Damonte C, Mortara L, Bruno A, Mora B, Brociner M, Mattarucchi R, Ingrassia A, Sirocchi D, Bianchi B, Agnoli S, Gallazzi M, Merli M, Ferrario A, Bombelli R, Barraco D, Baj A, Bertù L, Grossi PA, Passamonti F. Salvini M, et al. Among authors: brociner m. Bone Marrow Transplant. 2022 Jan;57(1):137-139. doi: 10.1038/s41409-021-01487-4. Epub 2021 Oct 11. Bone Marrow Transplant. 2022. PMID: 34635796 Free PMC article. No abstract available.
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
Varettoni M, Zibellini S, Boveri E, Klersy C, Candido C, Rattotti S, Ferretti VV, Defrancesco I, Mangiacavalli S, Nizzoli ME, Flospergher E, Zerbi C, Bergamini F, Benvenuti P, Brociner M, Merati G, Paulli M, Arcaini L. Varettoni M, et al. Among authors: brociner m. Br J Haematol. 2019 Nov;187(4):441-446. doi: 10.1111/bjh.16086. Epub 2019 Jul 5. Br J Haematol. 2019. PMID: 31276195 Free article.
A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group.
Marchesi F, Cattaneo C, Criscuolo M, Delia M, Dargenio M, Del Principe MI, Spadea A, Fracchiolla NS, Melillo L, Perruccio K, Alati C, Russo D, Garzia M, Brociner M, Cefalo M, Armiento D, Cesaro S, Decembrino N, Mengarelli A, Tumbarello M, Busca A, Pagano L; Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) Group. Marchesi F, et al. Among authors: brociner m. Am J Hematol. 2019 Oct;94(10):1104-1112. doi: 10.1002/ajh.25585. Epub 2019 Aug 9. Am J Hematol. 2019. PMID: 31321791 Free article.